cover image: South Centre News on AMR No. 62, 24 September 2024 The United Nations High-level Meeting on Antimicrobial Resistance on September 26, 2024: Uniting to Enable the Global Response to the Silent

20.500.12592/6bpvquq

South Centre News on AMR No. 62, 24 September 2024 The United Nations High-level Meeting on Antimicrobial Resistance on September 26, 2024: Uniting to Enable the Global Response to the Silent

25 Sep 2024

Its text has gone through various negotiation rounds, with a final version transmitted by the co-chairs of the process to the President of the General Assembly on 9 September, with the understanding that the draft can achieve consensus among Member States.(7) The Political Declaration of the High Level Meeting on AMR in 2024 The High-Level Meeting and its resulting declaration is an opportunity to. [...] After the High-Level Meeting on AMR, the next opportunity to do so will be at the 4th Ministerial Conference on AMR to be held in November 2024 in Saudi Arabia, and the updating of the Global Action Plan on AMR to further guide and catalyse policy action to address AMR.(12) The following are some of the highlights of commitments in the 2024 political declaration on AMR: Global target on reduction. [...] Countries also commit to ensure that the use of antimicrobials in animals and agriculture is done in a prudent and responsible manner in line with the Codex Alimentarius Antimicrobial Resistance Standards and the standards, guidance and recommendations of the World Organisation for Animal Health (WOAH). [...] Addressing the environmental dimensions of AMR: The declaration underscores the need for priority actions to prevent and address the discharge of antimicrobials and their metabolites into the environment from a wide range of sectors and services, including sanitation and sewage, waste, wastewater, healthcare, pharmaceutical manufacturing, crop production and terrestrial and aquatic animal producti. [...] Support for local and regional production: The declaration recognizes the need to support developing countries to build expertise and strengthen local and regional production of vaccines, medicines, diagnostics and other health technologies in order to facilitate equitable access, recognizing that the high prices of some health products and the inequitable access to such products impede progress t.

Authors

Anna Bernardo

Pages
10
Published in
Switzerland

Table of Contents